Director, External Innovation & Early TA Strategy

The VIOS Clinic; Waltham (MA); On-site; USD 130,000 - 170,000; Full time

Job summary

The VIOS Clinic is seeking a Director, Search & Evaluation Early TA Lead to spearhead the development of early therapeutic area strategy across biotechnology and pharmaceuticals. You will identify and prioritize external opportunities—assets, platforms, and partnerships— aligned with biotherapies, vaccines, and plasma-derived offerings.

You will lead due diligence across scientific, clinical, and business considerations and partner with R&D, commercial, and corporate development teams to inform

Qualifications

• Experience shaping early therapeutic area strategy and assessing external innovation.
• Ability to lead due diligence and translate findings into executive recommendations.
• Strong cross-functional collaboration with R&D, commercial, and corporate development teams.

Responsibilities

• Conduct evidence-based evaluation of external opportunities and recommend actions to senior leadership.
• Lead due diligence across scientific, clinical, and business considerations.
• Partner with R&D, commercial, and corporate development teams to inform portfolio strategy.
• Shape early TA portfolio direction and investment priorities.
• Mentor and manage a small team to support search and evaluation activities.
• Represent the organization in key scientific, clinical, and business forums globally.

Skills

Early TA strategy

Due diligence leadership

Cross-functional collaboration

Leadership & mentoring

Scientific/clinical/business comms

Job description

The VIOS Clinic is seeking a Director, Search & Evaluation Early TA Lead to spearhead the development of early therapeutic area strategy across biotechnology and pharmaceuticals. You will identify and prioritize external opportunities—assets, platforms, and partnerships— aligned with biotherapies, vaccines, and plasma-derived offerings.

You will lead due diligence across scientific, clinical, and business considerations and partner with R&D, commercial, and corporate development teams to inform